Eledon Presents Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation
03 juin 2024 16h01 HE
|
Eledon Pharmaceuticals, Inc.
Eledon Presents Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation
Favorable Oncocyte VitaGraft Kidney Study Results Published in the New England Journal of Medicine
30 mai 2024 16h47 HE
|
OncoCyte Corporation
Late-breaking presentation of data at American Transplant Congress on Monday, June 3Data show potential to monitor for therapeutic efficacy and recurrencePotential repeat testing opportunities with...
American Kidney Fund’s New Know Your Kidneys Program Provides Roadmap to Better Kidney Health
13 mai 2024 10h09 HE
|
American Kidney Fund
ROCKVILLE, Md., May 13, 2024 (GLOBE NEWSWIRE) -- Today, the American Kidney Fund (AKF) announced a major expansion of its award-winning Know Your Kidneys program, providing people at risk for kidney...
Eledon Pharmaceuticals Reports First Quarter 2024 Operating and Financial Results
09 mai 2024 07h30 HE
|
Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals Reports First Quarter 2024 Operating and Financial Results
Eledon Pharmaceuticals to Present Updated Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at the American Transplant Congress
09 mai 2024 07h00 HE
|
Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals to Present Updated Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at ATC 2024
Eledon Announces Clinical Progress with Tegoprubart in the Prevention of Transplant Rejection
07 mai 2024 07h05 HE
|
Eledon Pharmaceuticals, Inc.
Eledon Announces Clinical Progress with Tegoprubart in the Prevention of Transplant Rejection
Eledon Pharmaceuticals Announces Oversubscribed $50 Million Private Placement
07 mai 2024 07h00 HE
|
Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals Announces Oversubscribed $50 Million Private Placement
American Kidney Fund Encourages People to Be APOL1 Aware with First Annual APOL1-Mediated Kidney Disease (AMKD) Awareness Day
30 avr. 2024 09h14 HE
|
American Kidney Fund
ROCKVILLE, Md., April 30, 2024 (GLOBE NEWSWIRE) -- Today marks the nation’s first ever APOL1-Mediated Kidney Disease (AMKD) Awareness Day, launched this year by the American Kidney Fund (AKF) to...
American Kidney Fund Launches National Kidney Health Equity Media Campaign
25 avr. 2024 09h01 HE
|
American Kidney Fund
ROCKVILLE, Md., April 25, 2024 (GLOBE NEWSWIRE) -- As part of its longstanding commitment to kidney health equity, the American Kidney Fund (AKF) has launched a national media campaign aimed at...
American Kidney Fund Recognized as a Top Nonprofit Workplace in the United States
23 avr. 2024 09h40 HE
|
American Kidney Fund
ROCKVILLE, Md., April 23, 2024 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) is pleased to announce that it has been selected as one of the top 50 nonprofit employers in the United States by...